Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Synta Pharmaceuticals (SNTA)

Add to Watchlists
Create an Alert
4.19 +0.00  +0.00% NASDAQ Apr 24, 11:10AM BATS Real time Currency in USD
View Full Chart
SNTA Price Chart
View All Events

SNTA Events

Date Type Description
Mar 11 Misc Synta Pharmaceuticals, Inc. Q4 2013 Earnings Conference Call
Mar 11 Earnings Synta Pharmaceuticals, Inc. Q4 2013 Earnings Results. Estimate: -0.31.
Nov 04 Misc Q3 2013 Synta Pharmaceuticals Corp. Earnings Conference Call
Nov 04 Earnings Q3 2013 Synta Pharmaceuticals Corp. Earnings Results. Estimate: -0.31.
Sep 10 Misc Hdc Platform Launch Conference Call
Aug 01 Earnings Synta to Host Conference Call and Webcast of Second Quarter 2013 Financial Results. Estimate: -0.33.
Aug 01 Misc Q2 2013 Synta Pharmaceuticals Corp. Earnings Conference Call
Jun 13 Misc AGM Event for Synta Pharmaceuticals Inc.
Apr 30 Misc Q1 2013 Synta Pharmaceuticals Corp. Earnings Conference Call
Apr 30 Earnings Synta to Host Conference Call and Webcast of First Quarter 2013 Financial Results on April 30, 2013. Estimate: -0.28.
View All Performance Charts

SNTA Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Synta Pharmaceuticals is down 58.64% over the last year vs S&P 500 Total Return up 21.64%, Actelion up 67.22%, and Alexion Pharmaceuticals up 74.70%.

Get Quote for
Advertisement

Portfolio Strategies Featuring SNTA

Did Synta Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

SNTA Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Synta Pharmaceuticals Corp is a biopharmaceutical company, engaged in discovering, developing and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions.

Recent Quotes

Symbol Price Chg Chg % Market Cap
SNTA 4.19 +0.00 +0.00% 357.12M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.